Hamilton Health Sciences Corporation: all 241 studies

Page 3 of 3. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.

• Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac CatheterizationCompletedNCT00317252Phase 2
• Effectiveness of Domperidone to Increase Breastmilk Supply in Mothers With Low SupplyTerminatedNCT00284024Phase 2
• Two Approaches to Providing HIV/AIDS Services in the Community to People Living With HIV/AIDSStatus unknownNCT00280449Phase 1
• Role of Epicardial Adipose Tissue in Coronary Artery DiseaseStatus unknownNCT00279227
• Patients Preference With Self-Injection: The PRISM StudyCompletedNCT00253396Phase 4
• (Mol-SHARE) Molecular Study of Health Assessment and Risk in Ethnic GroupsStatus unknownNCT00249314
• Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders ClinicTerminatedNCT00248027
• Development of an Algorithm to Better Predict Clinical Responsiveness to PeanutStatus unknownNCT00243555
• Nasal Lavage Study: Comparing Single Versus Multi Sample LavagesCompletedNCT00229190Not applicable
• Community Hypertension Assessment Trial (CHAT)CompletedNCT00217334Not applicable
• Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)Status unknownNCT00217178Phase 4
• Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2CompletedNCT00197522Phase 1
• Sit-to-Stand Training for Survivors of Stroke in a Long-Term Care SettingStatus unknownNCT00197509Phase 2
• Canadian Pulmonary Embolism Diagnosis Study (CANPEDS)TerminatedNCT00182546Phase 3
• Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood DisordersTerminatedNCT00182533Phase 4
• Olanzapine in the Treatment of Hair Pulling (Trichotillomania)CompletedNCT00182507Phase 4
• Diabetes Prevention Program in Schizophrenia [DPPS]Status unknownNCT00182494Phase 4
• LOMA: Long-Term Management of AsthmaCompletedNCT00182481Not applicable
• Cognition, Functioning and Quality of LifeCompletedNCT00182442Phase 4
• Second Canadian Trial of Physiologic Pacing (CTOPP II): Pilot TrialCompletedNCT00182416Phase 3
• Pentastarch Use in Cardiac SurgeryStatus unknownNCT00182377Not applicable
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)CompletedNCT00182364Phase 3
• D-Dimer Vs Serial Compression Ultrasound StudyCompletedNCT00182351Phase 3
• An RCT to Compare the Outcomes of Patients With Large Rotator Cuff Repair That Undergo Repair With or Without SISStatus unknownNCT00182299Phase 4
• Evaluation of Continuity of Care at a Health Service OrganizationCompletedNCT00182286
• D-Dimer and IPG for Recurrent Thrombosis (DIRECT)TerminatedNCT00182247Phase 3
• Evaluation of a Venous-Return Assist Device (Venowave) to Treat Post-Thrombotic Syndrome: A Randomized Controlled TrialCompletedNCT00182208Phase 3
• Lung Open Ventilation to Decrease Mortality in the Acute Respiratory Distress SyndromeCompletedNCT00182195Phase 3
• Evaluation of a Primary Care Based Heart Failure Management ProgramStatus unknownNCT00182182Phase 2/3
• Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart FailureCompletedNCT00182169Phase 2
• Quality Initiative in Rectal Cancer (QIRC) TrialStatus unknownNCT00182130Not applicable
• Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis PopulationStatus unknownNCT00182117
• International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan ProceduresCompletedNCT00182104Phase 4
• POISE Trial: Perioperative Ischemic Evaluation StudyTerminatedNCT00182039Phase 3
• Long Study - Longitudinal Thrombosis in End Stage Renal DiseaseStatus unknownNCT00157664
• Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis CathetersCompletedNCT00157651Phase 3
• Integrating Family Medicine and Pharmacy to Advance Primary Care TherapeuticsCompletedNCT00157638Phase 4
• Quality of Life Among Breast Reduction PatientsCompletedNCT00149370
• The Effects of Two Education Strategies About Insulin on Patient Preferences and Perceptions About Insulin TherapyCompletedNCT00149331Phase 4
• Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)CompletedNCT00138099
• HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)Status unknownNCT00106886Phase 4

← Hamilton Health Sciences Corporation overview and focus areas